![David Loomis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermogen: 334 004 $ op 30-06-2026
Mr. David Loomis is a Chief Accounting Officer & Vice President at Arvinas, Inc. Mr. Loomis was previously employed as a Controller by Biohaven Ltd. and a Controller by Biohaven Pharmaceutical Holding Co. Ltd.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ARVINAS, INC. 0,06% | 11-05-2026 | 40.193 ( 0,06% ) | 334 004 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ARVINAS, INC. | Comptroller/Controller/Auditor | 07-11-2022 |
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Comptroller/Controller/Auditor | 01-11-2022 |
| BIOHAVEN LTD. | Comptroller/Controller/Auditor | 01-11-2022 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric diseases | Health Technology |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
Biohaven Ltd.
 Biohaven Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau
